Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Webcasting The New Norm During COVID-19 As FDA Reschedules Opthalmic AdComm Panel

Executive Summary

In a sign of the times, regulators are holding an advisory committee meeting for an ophthalmic device online because of the pandemic.

You may also be interested in...

FDA Makes 2nd Attempt At Virtual MDUFA Public Meeting

For the second time in the past few months the US agency has rescheduled a webcast of a public meeting meant to start MDUFA V user-fee negotiations.

FDA To Virtually Convene Orthopedic Panel

In a sign the US FDA is trying to address key issues not related to COVID-19, the agency is bringing together an expert panel almost five months after it was originally slated to meet to discuss classifying a slew of orthopedic devices.

No End In Sight: FDA Postpones Another In-Person Meeting Due To COVID-19

The US agency had planned to hold an in-person meeting of its ophthalmic advisory committee in early June, indicating hope that things would be back to some form of normal by then. But due to the ongoing coronavirus pandemic, it has postponed that meeting until further notice.

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts